Comprehensive Psychiatry
Volume 50, Issue 3 , Pages 200-208 , May 2009

Remission in schizophrenia: analysis in a naturalistic setting

  • Jonas Eberhard

      Affiliations

    • Department of Clinical Science, Lund University, SE-22185 Lund, Sweden
    • Corresponding Author InformationCorresponding author.
    • ,
  • Sten Levander

      Affiliations

    • Department of Health and Society, Malmö University, Malmö, Sweden
    • ,
  • Eva Lindström

      Affiliations

    • Department of Clinical Science, Lund University, SE-22185 Lund, Sweden

References 

  1. Hegarty J, Baldessarini R, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry. 1994;151:1409–1416
  2. Morel B. Traite des maladies mentales. Paris: Masson; 1860;
  3. Jackson H. Remarks on evolution and dissolution of the nervous system. J Ment Sci. 1894;33:25–48
  4. Kraepelin E. Dementia Praecox and paraphrenia. New York: Krieger; 1919;
  5. Johnstone E, Crow T, Frith C, Stevens M, Kreel L, Husband J. The dementia of dementia praecox. Acta Psychiatr Scand. 1978;57:305–324
  6. Johnstone E, Owens D, Frith C, Crow T. The relative stability of positive and negative features in chronic schizophrenia. Br J Psychiatry. 1986;150:60–64
  7. Tandon R, Greden J. Cholinergic hyperactivity and negative schizophrenic symptoms: a model of cholinergic-dopaminergic interactions in schizophrenia. Arch Gen Psychiatry. 1989;46:745–753
  8. Green M, Nuechterlein K, Gold J, Barch D, Cohen J, Essok S, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry. 2004;56:301–307
  9. Lieberman R, Kopelowicz A. Recovery from schizophrenia: a concept in search of research. Psychiatr Serv. 2005;56:735–742
  10. Andreasen N, Carpenter W, Kane J, Lasser R, Marder S, Weinberger D. Remission in schizophrenia: proposed criteria and rational for consensus. Am J Psychiatry. 2005;162:441–449
  11. Leucht S, Davis J, Engel R, Kissling W, Kane J. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation. Acta Psychiatr Scand [in press].
  12. Kay S, Fiszbein A, Opler L. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–276
  13. De Hert M, van Winkel R, Wampers M, Kane J, van Os J, Peuskens J. Remission criteria for schizophrenia: evaluation in a large naturalistic cohort. Schizophr Res. 2007;92(1-3):68–73
  14. Peuskens J, Kane J, Nasrallah H. Symptomatic remission in schizophrenia: reflections on a new concept and a visual representation of its course. [in press].
  15. American Psychiatric Association, APA . Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed.. Washington, DC: American Psychiatric Press; 1994;
  16. WHO . ICD-10. Classification of Mental and Behavioral disorders —diagnostic criteria for research. Geneva: World Health Organization; 1993;
  17. van Os J, Burns T, Cavallaro R, Leucht S, Peuskens J, Helldin L, et al. Standarized remission criteria in schizophrenia. Acta Psychiatr Scand. 2006;113:91–95
  18. Bellack A. Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophr Bull. 2006;32:432–442
  19. Kaplan A. Remission of schizophrenia: a possibility?. http://www.healthrising.com/stories/schrem.html2000;
  20. Harrow M, Sands J, Silverstein M, Goldberg J. Course and outcome for schizophrenia versus other psychotic patients: a longitudinal study. Schizophr Bull. 1997;23:287–303
  21. Remington G, Shammi C. Overstating the case about recovery?. Psychiatr Serv. 2005;56:1022
  22. Buckley PF, Wirshing DA, Bhushan P, Pierre JM, Resnick SA, Wirshing WC. Lack of insight in schizophrenia—impact on treatment adherence. CNS Drugs. 2007;21:129–141
  23. Lindström E, Eberhard J, Levander S. Five years follow up during antipsychotic treatment; efficacy, safety, functional and social outcome. Acta Psychiatr Scand. 2007;116(Suppl. 435):5–16
  24. von Knorring L, Lindström E. The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability. Acta Psychiatr Scand. 1992;86:463–468
  25. Guy W. Clinical global impressions. In: ECDEU assessment manual for psychopharmacology, revised (DHEW Publ No ADM 76-338). Rockville (MD): National Institute of Mental Health; 1976;p. 218–222
  26. Strauss JS, Carpenter W. The prediction of outcome in schizophrenia. Arch Gen Psychiatry. 1972;27:739–746
  27. Lindström E, Eriksson B, Hellgren A, von Knorring L, Eberhard G. Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia. Clin Ther. 1995;17:402–412
  28. Eberhard J, Riley F, Levander S. Premorbid IQ and schizophrenia. Increasing cognitive reduction by episodes. Eur Arch Psychiatr Clin Neurosci. 2003;253:84–88
  29. Eberhard J, Lindström E, Levander S. Poor insight in schizophrenia is associated with low premorbid IQ and executive functioning, but not with failure to self-monitor. [in press].
  30. Levander S, Eberhard J, Lindström E. Clinical decision-making during five years of antipsychotic treatment. Acta Psychiatr Scand. 2007;116(Suppl. 435):17–26
  31. Eberhard J, Lindström E, Levander S. Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course. Int Clin Psychopharmacol. 2006;21:35–42
  32. Levander S. Central cognitive deficits in schizophrenia. In:  Morgan KD,  David AS,  David RM,  Murray RM,  Eberhard J editor. Cognition and schizophrenia: improving real life function. Cambridge, England: Cambridge Medical Communications; 2006;p. 49–52
  33. Green M. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry. 1996;153:321–330
  34. Haro J, Salvador-Carulla L. The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia. CNS Drugs. 2006;20:293–301
  35. Helldin L, Kane J, Karilampi U, Norlander T, Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. J Psychiatr Res. 2006;40:738–745
  36. Jensen J, Nilsson L, Levander S. Neurocognitive and psychopathological correlates of self-monitoring ability in schizophrenia. Eur Arch Psychiatr Clin Neurosci. 2004;254:312–317
  37. Leucht S, Kane J, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale scores. Br J Psychiatry. 2005;187:366–371
  38. Remington G, Kapur S. Remission: what is in a name?. Am J Psychiatry. 2005;162:2393–2394
  39. Harrow M, Grossman LS, Jobe TH, Herbener ES. Do patients with schizophrenia ever show periods of recovery? A 15-yers multi-follow-up study. Schizophr Bull. 2005;31:723–734

PII: S0010-440X(08)00122-3

doi: 10.1016/j.comppsych.2008.08.010

Comprehensive Psychiatry
Volume 50, Issue 3 , Pages 200-208 , May 2009

Article Tools

* Image Usage & Resolution